Unity Biotechnology

Unity Biotechnology, Inc.
Company typePublic
IndustryBiotechnology, Pharmaceutical
PredecessorForge, Inc.
Founded2011; 13 years ago (2011) in California, U.S.
Founders
Headquarters,
United States
Number of employees
70 (2018)
Websiteunitybiotechnology.com

Unity Biotechnology, Inc. is a publicly traded American biotechnology company that develops drugs that target senescent cells.[1][2][3][4][5]

  1. ^ Brueck, Hilary (3 February 2016). "Mayo Clinic Taps Silicon Valley to Help People Age Gracefully". Fortune. Retrieved 19 February 2018.
  2. ^ Detrixhe, John (21 February 2018). "Crypto millionaires are funding research to reverse the aging process". Quartz (publication). Retrieved 19 February 2018.
  3. ^ Herkewitz, William (19 February 2018). "Scientists Can Now Radically Expand the Lifespan of Mice—and Humans May Be Next". Popular Mechanics. Retrieved 19 February 2018.
  4. ^ Ramsey, Lydia (10 November 2016). "A biotech startup that aims to rid our bodies of cells related to aging just got a big investment". Business Insider. Retrieved 19 February 2018.
  5. ^ Baker, Darren (11 February 2016). "Naturally occurring p16Ink4a-positive cells shorten healthy lifespan". Nature. 530 (7589): 184–189. doi:10.1038/nature16932. PMC 4845101. PMID 26840489.